GE HealthCare's Flyrcado, a radiotracer for diagnosing coronary heart disease, has gained FDA approval. With a longer half-life than existing tracers, it offers potential for expanded clinician and patient access to PET MPI. It will be available in the U.S.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing